Development of a new anabolic peptide on bone by the identification
通过鉴定开发出一种新型骨合成代谢肽
基本信息
- 批准号:23659867
- 负责人:
- 金额:$ 2.33万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Challenging Exploratory Research
- 财政年份:2011
- 资助国家:日本
- 起止时间:2011 至 2012
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Receptor activator of NF-〓B ligand (RANKL) promotes dendritic celldifferentiation and osteoclast differentiation and function. Recent findings also revealedthe wide-ranging physiological roles of RANKL such as the mammalian gland developmentand the thermoregulation. We found in this study that RANKL binding peptides promotebone formation, leading to a significant finding to clarify the physiological roles of RANKL. This study yields the important finding that anabolic activity on bone formationwas dependent on the RANKL-reverse-signaling intensity. The comparison of boneformation activities between two RANKL-binding peptides guided us to this conclusion. Atthe beginning of this study, we hypothesized that the differences of RANKL binding sitesbetween two anabolic peptides might induce the differences of bone formation activitiesbetween the two peptides. Since the stimulatory effects of osteoblast differentiation wasappeared only when the peptide concentration was higher around100 〓M and over, wethought that making a RANKL clustering on the surface of osteoblast membrane might bea trigger of the RANKL-reverse-signaling. Further studies are necessary for leading this study toward the development of anew therapeutic agent, such as clarification of an appropriate distance between RANKLmolecules that can switch on the bone formation activity, and the development of a ligand,which can make a RANKL clustering. Finally we thank Dr. Masashi Honma (Department of Pharmacy, TheUniversity of Tokyo Hospital, Faculty of Medicine) for analyses of the bone formationpeptides on the RANKL-reverse-signaling.
NF-〓B 配体受体激活剂 (RANKL) 促进树突状细胞分化和破骨细胞分化和功能。最近的研究结果还揭示了 RANKL 的广泛生理作用,例如哺乳动物腺体发育和温度调节。我们在这项研究中发现 RANKL 结合。肽促进骨形成,从而得出澄清 RANKL 生理作用的重要发现。这项研究得出的重要发现是,骨形成的合成代谢活性取决于。两种 RANKL 结合肽之间的骨形成活性的比较引导我们得出这一结论。在本研究开始时,我们发现两种合成代谢肽之间的 RANKL 结合位点的差异可能导致 RANKL 反向信号强度的差异。由于只有当肽浓度高于100〓M及以上时才会出现成骨细胞分化的刺激作用,因此我们认为。在成骨细胞膜表面形成 RANKL 簇可能是 RANKL 反向信号传导的触发因素,为了引导这项研究开发新的治疗剂,例如澄清可以切换的 RANKL 分子之间的适当距离,有必要进行进一步的研究。最后我们感谢 Masashi Honma 博士(东京大学药学系)。医学院)用于分析 RANKL 反向信号传导的骨形成肽。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
マウス抜歯モデルを用いた骨形成評価法‐骨吸収抑制作用のある薬剤の骨形成促進効果の検討‐
使用小鼠拔牙模型的骨形成评价方法 - 抑制骨吸收的药物的骨形成促进效果的检查 -
- DOI:
- 发表时间:2012
- 期刊:
- 影响因子:0
- 作者:青木和広;田村幸彦;大谷啓一.
- 通讯作者:大谷啓一.
A Bone Resorption Inhibitor Promotes Bone Formation
骨吸收抑制剂促进骨形成
- DOI:
- 发表时间:2011
- 期刊:
- 影响因子:0
- 作者:妹尾吉訓;青木和広.;M.Khan,K.Aoki.
- 通讯作者:M.Khan,K.Aoki.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
AOKI Kazuhiro其他文献
AOKI Kazuhiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('AOKI Kazuhiro', 18)}}的其他基金
A challenge to establish a model for inducing carcinogenesis and thrombus formation by continuous endovascular inoculation of oral bacteria.
建立通过口腔细菌连续血管内接种诱导癌变和血栓形成模型的挑战。
- 批准号:
18K19637 - 财政年份:2018
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Quantitative understanding of the mechanism of G1-S phase checkpoint regulated by ERK signal
定量理解ERK信号调控G1-S期检查点的机制
- 批准号:
18H02444 - 财政年份:2018
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Systems analysis of intrinsic resistance to MEK inhibitor in KRas- or BRaf-mutataed cancer cells
KRas 或 BRaf 突变癌细胞对 MEK 抑制剂内在耐药性的系统分析
- 批准号:
26290053 - 财政年份:2014
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of a new drug candidate to stimulate bone formation by oligomerization of RANKL-binding peptides
开发一种通过 RANKL 结合肽寡聚刺激骨形成的新候选药物
- 批准号:
25293377 - 财政年份:2013
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Suggestion of bounding in the evaluation method of the ability for jump
跳跃能力评价方法中的界限建议
- 批准号:
24500755 - 财政年份:2012
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Systematic analysis of Ras/ERK pathway with FRET imaging
利用 FRET 成像系统分析 Ras/ERK 通路
- 批准号:
23701052 - 财政年份:2011
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Analysis of mechanisms of ERK MAP kinase phosphorylation
ERK MAP激酶磷酸化机制分析
- 批准号:
21790273 - 财政年份:2009
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Development of peptide-delivery system using nanogel carrier for the control release of the peptide as the inhibitor of bone resorption toward clinical applications
开发使用纳米凝胶载体的肽递送系统,用于控制肽的释放作为骨吸收抑制剂的临床应用
- 批准号:
19390472 - 财政年份:2007
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The functional analysis of RANKL signaling in osteoclast for developing the agonist of SHP-1
破骨细胞中RANKL信号传导的功能分析用于开发SHP-1激动剂
- 批准号:
16390530 - 财政年份:2004
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of therapeutic RANKL vaccination approach against inflammatory alveolar-bone-destruction
开发针对炎症性牙槽骨破坏的治疗性 RANKL 疫苗接种方法
- 批准号:
14370589 - 财政年份:2002
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似海外基金
Analysis and clinical application of new function of osteoprotegerin as anti-aging factor
护骨素抗衰老因子新功能分析及临床应用
- 批准号:
17K19776 - 财政年份:2017
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Elucidation of Wnt signaling network controlling bone metabolism
阐明控制骨代谢的Wnt信号网络
- 批准号:
25221310 - 财政年份:2013
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Expression and function of RANKL in gingival epithelialum
牙龈上皮中RANKL的表达及功能
- 批准号:
23792487 - 财政年份:2011
- 资助金额:
$ 2.33万 - 项目类别:
Grant-in-Aid for Young Scientists (B)